Cargando…
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
The process of stool transfer from healthy donors to the sick, known as faecal microbiota transplantation (FMT), has an ancient history. However, only recently researchers started investigating its applications in an evidence-based manner. Current knowledge of the microbiome, the concept of dysbiosi...
Autores principales: | Sbahi, Hani, Di Palma, Jack A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873946/ https://www.ncbi.nlm.nih.gov/pubmed/27239328 http://dx.doi.org/10.1136/bmjgast-2016-000087 |
Ejemplares similares
-
Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018) -
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019) -
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020) -
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021) -
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)